Ms. Helge Hentschel joined Syntellix AG in April 2015 as a commercial director and authorized signatory. Syntellix AG is a young, internationally growing medical technology company (www.syntellix.com) specializing in research & development and the sale of innovative bioabsorbable metallic implants. Since then, Ms. Hentschel has been involved in the international expansion of the company’s commercial focus (finance, controlling, human resources, legal affairs, risk management, etc.). Previously, Ms. Hentschel held various management positions in the energy industry, including Head of Group Auditing and Member of the Board of Management of a medium-sized group, and has also assumed responsibility in advisory board functions.
Ms. Hentschel holds a degree in economics from the Leibniz University of Hannover.